Richard Tozer
Overview
Explore the profile of Richard Tozer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
954
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Goss P, Ingle J, Pritchard K, Ellis M, Sledge G, Budd G, et al.
J Clin Oncol
. 2013 Jan;
31(11):1398-404.
PMID: 23358971
Purpose: In patients with hormone-dependent postmenopausal breast cancer, standard adjuvant therapy involves 5 years of the nonsteroidal aromatase inhibitors anastrozole and letrozole. The steroidal inhibitor exemestane is partially non-cross-resistant with...
12.
Granek L, Krzyzanowska M, Tozer R, Mazzotta P
J Palliat Med
. 2012 Sep;
15(11):1254-60.
PMID: 23016965
Background: While caring for critically ill and terminal patients can elicit grief symptoms in health care professionals, few studies have examined oncologists' grief over patient loss using a qualitative approach...
13.
Petrella T, Tozer R, Belanger K, Savage K, Wong R, Smylie M, et al.
J Clin Oncol
. 2012 Aug;
30(27):3396-401.
PMID: 22915661
Purpose: We report a multicenter phase II study of patients with metastatic melanoma (MM), evaluating the efficacy, toxicity, progression-free survival (PFS), immunogenicity, and biomarker profile of interleukin-21 (IL-21). Patients And...
14.
Granek L, Tozer R, Mazzotta P, Ramjaun A, Krzyzanowska M
Arch Intern Med
. 2012 Jun;
172(12):964-6.
PMID: 22732754
No abstract available.
15.
Granek L, Mazzotta P, Tozer R, Krzyzanowska M
Support Care Cancer
. 2012 Jun;
20(10):2627-32.
PMID: 22714702
Purpose: The purpose of the study was to explore what institutional support(s) oncologists want to help them cope with patient loss. Methods: The grounded theory method was used. Twenty oncologists...
16.
Tap W, Demetri G, Barnette P, Desai J, Kavan P, Tozer R, et al.
J Clin Oncol
. 2012 Apr;
30(15):1849-56.
PMID: 22508822
Purpose: Ganitumab is a fully human monoclonal antibody against type-1 insulin-like growth factor receptor (IGF1R). An open-label phase II study was conducted to evaluate the efficacy and safety of ganitumab...
17.
Francescutti V, Farrokhyar F, Tozer R, Heller B, Lovrics P, Jansz G, et al.
Cancer Chemother Pharmacol
. 2010 Dec;
68(3):661-8.
PMID: 21125276
Purpose: Adjuvant therapy reduces the risk of recurrence of breast cancer. This study was undertaken to determine characteristics guiding choice of adjuvant therapy. Methods: A retrospective review was completed of...
18.
Szabo K, Webber C, Gordon C, Adachi J, Tozer R, Papaioannou A
Can Assoc Radiol J
. 2010 Jun;
62(3):183-9.
PMID: 20576400
Purpose: The objectives of this study were to utilise the XCT-2000 pQCT scanner to determine the mean values and the reproducibility of in vivo total, trabecular, and cortical volumetric bone...
19.
Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M
Cancer
. 2008 Jun;
113(3):573-81.
PMID: 18521899
Background: The use of adjuvant chemotherapy to treat adults with localized resectable soft-tissue sarcoma remains controversial. The objective of this systematic review was to update the 1997 meta-analysis of randomized...
20.
Neal M, Nagel K, Duckworth J, Bissessar H, Fischer M, Portwine C, et al.
Cancer
. 2007 Jul;
110(5):1125-9.
PMID: 17647219
Background: Improving success in the treatment of cancer has resulted in an increasing number of survivors. An important quality of life issue among younger survivors is the ability to have...